Eif2b1-KO 基因敲除小鼠

1. van der Knaap, Marjo S, Bugiani, Marianna, Abbink, Truus E M. . Vanishing white matter. In Handbook of clinical neurology, 204, 77-94. doi:10.1016/B978-0-323-99209-1.00015-6. https://pubmed.ncbi.nlm.nih.gov/39322396/

2. De Franco, Elisa, Caswell, Richard, Johnson, Matthew B, Ron, David, Hattersley, Andrew T. 2019. De Novo Mutations in EIF2B1 Affecting eIF2 Signaling Cause Neonatal/Early-Onset Diabetes and Transient Hepatic Dysfunction. In Diabetes, 69, 477-483. doi:10.2337/db19-1029. https://pubmed.ncbi.nlm.nih.gov/31882561/

3. Wek, Ronald C, Anthony, Tracy G, Staschke, Kirk A. 2023. Surviving and Adapting to Stress: Translational Control and the Integrated Stress Response. In Antioxidants & redox signaling, 39, 351-373. doi:10.1089/ars.2022.0123. https://pubmed.ncbi.nlm.nih.gov/36943285/

4. van der Knaap, Marjo S, Bonkowsky, Joshua L, Vanderver, Adeline, van de Ven, Peter, Leferink, Prisca S. 2022. Therapy Trial Design in Vanishing White Matter: An Expert Consortium Opinion. In Neurology. Genetics, 8, e657. doi:10.1212/NXG.0000000000000657. https://pubmed.ncbi.nlm.nih.gov/35128050/